R. J. Simes

17.1k total citations · 6 hit papers
144 papers, 12.0k citations indexed

About

R. J. Simes is a scholar working on Oncology, Electrical and Electronic Engineering and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, R. J. Simes has authored 144 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 37 papers in Electrical and Electronic Engineering and 34 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in R. J. Simes's work include Semiconductor Quantum Structures and Devices (32 papers), Semiconductor Lasers and Optical Devices (28 papers) and Photonic and Optical Devices (23 papers). R. J. Simes is often cited by papers focused on Semiconductor Quantum Structures and Devices (32 papers), Semiconductor Lasers and Optical Devices (28 papers) and Photonic and Optical Devices (23 papers). R. J. Simes collaborates with scholars based in Australia, United States and New Zealand. R. J. Simes's co-authors include John Zalcberg, Timothy Price, Niall C. Tebbutt, Joshua M. Stern, Christos S. Karapetis, Malcolm J. Moore, Derek J. Jonker, Dongsheng Tu, Christiane Langer and Chris J. O’Callaghan and has published in prestigious journals such as New England Journal of Medicine, Physical Review Letters and Circulation.

In The Last Decade

R. J. Simes

139 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

2008 2.8k citations Christos S. Karapetis, Shirin Khambata‐Ford et al. New England Journal of Medicine profile →
Cetuximab for the Treatment of Colorectal Cancer

2007 1.4k citations Derek J. Jonker, Chris J. O’Callaghan et al. New England Journal of Medicine profile →
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

2011 1.2k citations John Zalcberg, R. J. Simes et al. profile →
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

2005 696 citations Val Gebski, R. J. Simes et al. profile →
Publication bias: evidence of delayed publication in a cohort study of clinical research projects

1997 598 citations Joshua M. Stern, R. J. Simes BMJ profile →
Molecular-beam epitaxy growth of tilted GaAs/AlAs superlattices by deposition of fractional monolayers on vicinal (001) substrates

1988 226 citations J. M. Gaines, P. M. Petroff et al. profile →

Peers

R. J. Simes

ONCOL

PRM

SURGE

PFM

Barry A. Siegel United States

Lawrence B. Marks United States

G. Scott Gazelle United States

Hedvig Hricak United States

Søren M. Bentzen United States

Harry J. de Koning Netherlands

Harry J.M. Groen Netherlands

Robert T. Greenlee United States

Michael B. Wallace United States

Julia Brown United Kingdom

Barry A. Siegel United States

R. J. Simes

4.8k ×1.0

ONCOL

7.3k ×2.0

PRM

4.0k ×1.3

SURGE

2.4k ×1.7

2.0k ×1.5

PFM

Citations per year, relative to R. J. Simes R. J. Simes (= 1×) peers Barry A. Siegel

Countries citing papers authored by R. J. Simes

Since Specialization

Citations

This map shows the geographic impact of R. J. Simes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. J. Simes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. J. Simes more than expected).

Fields of papers citing papers by R. J. Simes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. J. Simes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. J. Simes. The network helps show where R. J. Simes may publish in the future.

Co-authorship network of co-authors of R. J. Simes

This figure shows the co-authorship network connecting the top 25 collaborators of R. J. Simes. A scholar is included among the top collaborators of R. J. Simes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. J. Simes. R. J. Simes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woodford, Rachel, Peey‐Sei Kok, Sarah J. Lord, et al.. (2024). Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials. JCO Precision Oncology. 8(8). e2300296–e2300296. 1 indexed citations

Bhatia, Harpreet, Simon Wandel, Peter Willeit, et al.. (2024). Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis. Circulation. 151(4). 312–321. 26 indexed citations

Brown, Bernadette, et al.. (2023). Clinicians’ Evaluation of Lung Cancer Clinical Quality Indicators and Comparative Performance Data in Practice. European Journal of Cancer Care. 2023. 1–11. 1 indexed citations

Woodford, Rachel, Peey‐Sei Kok, Sarah J. Lord, et al.. (2022). The validity of progression‐free survival 2 as a surrogate trial end point for overall survival. Cancer. 128(7). 1449–1457. 10 indexed citations

Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2020). Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 123(5). 868–868. 1 indexed citations

Tang, Mónica, Andrea L. Schaffer, Belinda E. Kiely, et al.. (2019). Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016). British Journal of Cancer. 121(11). 904–911. 12 indexed citations

Lee, Chee Khoon, Ian C. Marschner, R. J. Simes, et al.. (2012). Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus. Clinical Cancer Research. 18(11). 3188–3196. 53 indexed citations

Goel, Shom, R. J. Simes, & Jane Beith. (2011). Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer. Asia-Pacific Journal of Clinical Oncology. 7(3). 276–280. 23 indexed citations

Murphy, Felicity, Diana Zannino, Kate Wilson, et al.. (2011). Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. Annals of Oncology. 22(8). 1834–1838. 38 indexed citations

10.

Tebbutt, Niall C., Kate Wilson, Val Gebski, et al.. (2010). Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. Journal of Clinical Oncology. 28(19). 3191–3198. 315 indexed citations

11.

Grimison, Peter, Martin R. Stockler, Damien Thomson, et al.. (2010). Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial. JNCI Journal of the National Cancer Institute. 102(16). 1253–1262. 49 indexed citations

12.

Goel, Shom, et al.. (2010). Randomized cross‐over trial comparing inpatient and outpatient administration of high‐dose cisplatin. Internal Medicine Journal. 41(2). 172–178. 10 indexed citations

13.

Lee, Chee Khoon, Martin R. Stockler, Alan S. Coates, et al.. (2010). Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British Journal of Cancer. 102(9). 1341–1347. 36 indexed citations

14.

Karapetis, Christos S., Shirin Khambata‐Ford, Derek J. Jonker, et al.. (2008). K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer. New England Journal of Medicine. 359(17). 1757–1765. 2764 indexed citations breakdown →

15.

Lumley, Thomas, R. J. Simes, Val Gebski, & Harold Hudson. (2001). Combining components of quality of life to increase precision and evaluate trade‐offs. Statistics in Medicine. 20(21). 3231–3249. 9 indexed citations

16.

Stern, Joshua M. & R. J. Simes. (1997). Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ. 315(7109). 640–645. 598 indexed citations breakdown →

17.

Puma, Joseph, Michael H. Sketch, R. J. Simes, et al.. (1995). 725-1 Long-term Impact of a Patent Infarct-related Artery: 1-Year Survival In the GUSTO Trial. Journal of the American College of Cardiology. 25(2). 130A–130A. 2 indexed citations

18.

Geels, R.S., Ran Yan, J.W. Scott, et al.. (1988). Analysis and design of a novel parallel-driven MQW-DBR surface-emitting diode laser. Conference on Lasers and Electro-Optics. 10 indexed citations

19.

Gaines, J. M., P. M. Petroff, H. Kroemer, R. J. Simes, & R.S. Geels. (1988). Molecular-beam epitaxy growth of tilted GaAs/AlAs superlattices by deposition of fractional monolayers on vicinal (001) substrates. Journal of Vacuum Science and Technology. 6. 1378–1381. 2 indexed citations

20.

Simes, R. J., et al.. (1983). Conservative Surgery and Radiotherapy as Primary Treatment for Early Breast Cancer: Results of a 10 Year Experience. Australasian Radiology. 27(1). 50–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact